Andrew Philip Witty

Andrew Philip Witty
Andrew Philip Witty ; (businessman);
	At Chatham House in 2015
Born	A22 ugust 1964; UK
Residence	UK
Nationality	UK
	GlaxoSmithKline/CEO
In office
	2008 - 2017
	GlaxoSmithKline Consumer Healthcare Holdings/Director
In office
	2 March 2015 - 31 March 2017
	GlaxoSmithKline Consumer Healthcare Holdings/Director
In office
	2 March 2015 - 31 March 2017
	GlaxoSmithKline/Director
In office
	25 October 2005 - 31 March 2017
	British Pharma Group/Director
In office
	25 October 2005 - 31 March 2017

Sir Andrew Philip Witty is a big pharma executive involved in organising the response to COVID-19.

Activities

In April 2020, Witty began a leave of absence from Optum to assist the WHO in developing a vaccination for COVID-19.

In 2013 he reported he was "absolutely committed to rooting out corruption".^[1]

Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.

This is a page stub. Please add to it.